Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cullen High Dividend Equity Fund Class R1 (CHDRX)

13.70
Net Asset Value
-2.91%
1 Day
-11.90%
Year-to-Date
Overall Morningstar Rating
Large value
Style or Category
No Load
Sales Expenses
1.77%
Expense Ratio
Low
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation and current income; capital appreciation is a primary objective and current income is a secondary objective. The fund invests at least 80% of its net assets in dividend paying common stocks of medium- and large-capitalization companies. As a point of comparison, a high dividend common stock that the fund would invest in would generally have a dividend yield greater than the average dividend yield of the equity securities in the S&P 500  Index. The fund may invest up to 30% of its assets in foreign securities.

Performance

1 month-8.94% 3 years+7.18%
3 months-10.25% 5 years+9.52%
1 year-9.04% Since inception+11.16%
Data through --

Peer Comparisonvs. Large value

 CHDRXCategory
Performance 5-yr return+9.52%+15.03%
Expense ratio1.77%1.13%
Risk 5 year sharpe ratio1.261.12
Net assets$2.1B$2.5B
Average market cap$98.9B$82.1B
Average P/E17.116.4
Portfolio turnover10%10%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyCullen Funds Trust
Fund manager & tenureJames Cullen / 12 Years
Minimal initial investment$0.00
Minimum IRA investment--

Holdings

U.S. stock86.67%
International stock11.76%
Cash1.57%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Industrial materials 14.84%
Consumer goods 14.15%
Telecommunication 14.09%
Healthcare 13.92%
Financial service 12.38%
Top 10 Holdings
Portfolio weighting
JPM JPMorgan Chase4.63%
JNJ Johnson & Johnson4.01%
MMM 3M3.84%
MRK Merck3.83%
GE General Electric3.82%
T AT&T3.72%
CSCO Cisco3.71%
TRV Travelers Companies Inc3.68%
MET Metlife3.68%
RTN Raytheon3.60%

Partner Offers